We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+17.7%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$956M
AUM Growth
-$88.9M
Cap. Flow
-$124M
Cap. Flow %
-13%
Top 10 Hldgs %
51.28%
Holding
904
New
257
Increased
162
Reduced
180
Closed
232

Sector Composition

Rank Sector Weight
1 Healthcare 36.98%
2 Financials 14.53%
3 Materials 10.99%
4 Energy 8.52%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MASI
251
CALL
DELISTED
Masimo
MASI
$50K 0.01%
+40,000
New +$5.5M
AUROW
252
Aurora Innovation Warrant
AUROW
$300M
$49.2K 0.01%
378,318
+20,838
+6% +$5.92K
RADI
253
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
$49.1K 0.01%
+4,150
New +$43K
SNAXW
254
DELISTED
Stryve Foods, Inc. Warrant
SNAXW
$48.8K 0.01%
975,046
+200,689
+26% +$11.8K
SDAWW
255
SunCar Technology Group Warrant
SDAWW
$48.5K 0.01%
+648,157
New +$36.7K
GENQW
256
DELISTED
Genesis Unicorn Capital Corp. Warrants
GENQW
$47.9K 0.01%
1,063,453
+81,853
+8% +$4.3K
BURU.WS
257
DELISTED
Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
BURU.WS
$47.7K 0.01%
682,096
+28,245
+4% +$1.8K
LANV.WS
258
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
$47.7K 0.01%
+159,118
New +$41.8K
BTMDW
259
DELISTED
Biote Corp. Warrant
BTMDW
$44.5K ﹤0.01%
+148,298
New +$40.4K
BIIB icon
260
CALL
Biogen
BIIB
$30.4B
$43.3K ﹤0.01%
+10,900
New +$3.08M
LUNG icon
261
Pulmonx
LUNG
$98.4M
$43.2K ﹤0.01%
+5,126
New +$48.8K
BWAQR
262
DELISTED
Blue World Acquisition Corporation Right
BWAQR
$43K ﹤0.01%
538,020
-74,000
-12% -$6.73K
CDTTW
263
CDT Equity Inc Warrant
CDTTW
$1.63M
$43K ﹤0.01%
623,071
+401,871
+182% +$20.3K
SNDL icon
264
Sundial Growers
SNDL
$318M
$42.4K ﹤0.01%
20,310
GDSTR
265
DELISTED
Goldenstone Acquisition Limited Rights
GDSTR
$42.4K ﹤0.01%
471,568
+17,400
+4% +$1.65K
HERAW
266
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
$41.6K ﹤0.01%
1,514,041
+370,626
+32% +$15K
FLYX.WS icon
267
flyExclusive Inc Warrants
FLYX.WS
$41.6K ﹤0.01%
215,303
-125,131
-37% -$23.6K
WFC icon
268
CALL
Wells Fargo
WFC
$265B
$41.4K ﹤0.01%
+50,800
New +$2.25M
DMYS.WS
269
DELISTED
dMY Technology Group, Inc. VI Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
DMYS.WS
$41.2K ﹤0.01%
392,791
-98,292
-20% -$29.4K
BNIXR
270
DELISTED
Bannix Acquisition Corp. Right
BNIXR
$40.8K ﹤0.01%
480,577
+10,920
+2% +$889
BLEUR
271
DELISTED
bleuacacia ltd Rights
BLEUR
$40K ﹤0.01%
399,163
-503,670
-56% -$44.2K
PCT icon
272
CALL
PureCycle Technologies
PCT
$1.44B
$39.9K ﹤0.01%
+73,700
New +$531K
MKFG.WS
273
DELISTED
Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share
MKFG.WS
$39.7K ﹤0.01%
188,893
-39,485
-17% -$8.88K
VHAQ.RT
274
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
$39.1K ﹤0.01%
300,210
+62,177
+26% +$7.78K
FOA icon
275
Finance of America Companies
FOA
$196M
$38.8K ﹤0.01%
3,058

Similar funds

Cowen and Company's Q4 2022 Portfolio in Review

As of Q4 2022, Cowen and Company held 904 positions worth $956M, down 8.5% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cowen and Company withdrew a net $124M in Q4 2022, closing 232 positions and reducing 180 holdings. Its most notable exit was ARK Innovation ETF, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Financials and Materials.

Against the trend, Cowen and Company opened a new position in DCP Midstream, LP worth $58.8M.

  • Cowen and Company's largest Q4 2022 buy was DCP Midstream, LP: 1,516,562 shares worth $58.8M.
  • Cowen and Company added most to Adicet Bio in Q4 2022, an estimated $10.9M increase.
  • Cowen and Company's biggest Q4 2022 reduction was Immunocore, cutting an estimated $34.1M.
  • Cowen and Company fully exited ARK Innovation ETF in Q4 2022, selling an estimated $131M.
  • Cowen and Company's ten largest holdings make up 51% of its $956M portfolio in Q4 2022.
  • Cowen and Company opened 257 new positions and closed 232 in Q4 2022.
  • Cowen and Company's portfolio value fell 8.5% quarter-over-quarter to $956M.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.